Ironwood Pharmaceuticals (IRWD) Price to Book (2010 - 2026)

Ironwood Pharmaceuticals has disclosed Price to Book across 17 years of filings, most recently posting 4.3 for Q2 2026.

• In Q2 2026, Price to Book fell 1032.59% year-over-year to 4.3; the TTM figure through Jun 2026 stood at 4.3 (down 1032.59% YoY), while the FY2025 annual figure was 2.1, up 10.89% from the prior year.
• Price to Book came in at 4.3 for Q2 2026 at Ironwood Pharmaceuticals, down from 2.66 in the prior quarter.
• In the past five years, Price to Book ranged from a high of 3.77 in Q1 2022 to a low of 5.17 in Q4 2023.
• Average Price to Book over 5 years is 1.25, with a median of 2.11 recorded in 2024.
• Year-over-year, Price to Book surged 88.28% in 2025 and tumbled 1032.59% in 2026.
• Over 5 years, Price to Book stood at 2.93 in 2022, then plunged by 276.57% to 5.17 in 2023, then soared by 54.4% to 2.36 in 2024, then rose by 10.89% to 2.1 in 2025, then slumped by 104.81% to 4.3 in 2026.
• Per Business Quant data, the three most recent Price to Book figures were 4.3 in Q2 2026, 2.66 in Q1 2026, and 2.1 in Q4 2025.